<DOC>
	<DOCNO>NCT01820299</DOCNO>
	<brief_summary>This study subject solid cancer ( gastrointestinal , lung , breast , prostate , lymphoma cancer lymph node ) . The overall goal study identify plant-derived phytochemical safely reduce systemic inflammation ( inflammation throughout entire body ) subject advanced cancer .</brief_summary>
	<brief_title>Phase I Assay-guided Trial Anti-inflammatory Phytochemicals Patients With Advanced Cancer</brief_title>
	<detailed_description>This study look oligomeric procyanidin complex ( OPC ) vitamin D3 . OPC major part Grape Seed Extract ( GSE ) . Researchers look combination GSE vitamin D subject solid cancer ( gastrointestinal , lung , breast , prostate , lymphoma cancer lymph node ) . Researchers examine safety GSE vitamin D GSE give different dos . Researchers also look effect GSE vitamin D quality life body . In particular , look difference biomarkers blood urine .</detailed_description>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<mesh_term>Grape Seed Extract</mesh_term>
	<criteria>Subjects must histological diagnosis cancer Subjects must 21 year age Subjects must metastatic locally advanced , unresectable cancer . Cancer must `` active '' ( i.e . demonstrable physical examination , blood test , radiographical procedure ) . Subjects may initiate new form cancer therapy , nonsteroidal steroid antiinflammatory agent , antibiotic study period 4 week prior start study agent . Subjects must able give write consent study . Subjects must adequate hematologic , renal , hepatic function baseline , follow : Hematology parameter : ANC &gt; 1500/mcL , platelet &gt; 100,000/mcL , Hgb &gt; 8.0gm/dL Renal Function : Creatinine &lt; 1.8mg/mL Liver Function : Total bilirubin ≤ULN , AST ALT &lt; 1.5xULN , Alk phosphatase &lt; 2.5xULN Subjects must normal serum phosphate serum calcium level : Serum Phosphate &gt; 2.3 &lt; 4.8 mg/dL Serum Calcium &gt; 8.5 &lt; 10.5 Subjects may receive anticancer treatment , treatment institute least 4 week prior enrollment , may change study period . Uncontrolled cancer require institution new anticancer therapy study period . Presence severe uncontrolled concurrent medical condition , opinion investigator , would increase risk serious toxicity study drug . Any uncontrolled systemic inflammatory disease infection require antibiotic , nonsteroidal , steroidal antiinflammatory agent . Initiation strong antioxidant supplement treatment , ongoing use supplement contain concentrate plantderived polyphenols ( pine bark , grape seed , green tea , milk thistle extract ; resveratrol ; ellagic acid ) Pregnancy breast feed Any history allergy grapes grape seed . Current treatment lenalidomide , thalidomide , imipquimod , interferon , cytokine ( GCSF , GMCSF , IL1Rα ) , TNFα antagonists , Lithium . History sarcoidosis History hypercalcemia Use nonprotocol vitamin D supplementation . Uncontrolled hypertension Current treatment warfarin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>